Repetitive transcranial magnetic stimulation for cerebellar ataxia: a systematic review and meta-analysis
Authors:
Open Access
- 7 July 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1177746
Abstract
Background: Repetitive transcranial magnetic stimulation, a non-invasive brain stimulation technique, can manage cerebellar ataxia (CA) by suppressing cerebral cortical excitability. Hence, this study aimed to summarize the efficacy and safety of rTMS for CA patients by meta-analysis.Methods: The PubMed, Embase, Web of Science, and Cochrane Library databases were searched for eligible studies published till 20 May 2023. Weighted mean difference (MD) and 95% confidence intervals (CIs) were used to assess the effect of rTMS treatment. Additionally, the quality of the included studies and the risk of bias were evaluated using the Physiotherapy Evidence Database (PEDro) scale.Results: Overall, eight studies involving 278 CA patients were included in this meta-analysis. rTMS could significantly improve the Scale for the Assessment and Rating of Ataxia (SARA) (MD: −2.00; 95% CI: −3.97 to −0.02, p = 0.05), International Cooperative Ataxia Rating Scale (ICARS) (MD: −3.96; 95% CI: −5.51 to −2.40, p < 0.00001), Timed Up-and-Go test (TUG) (MD: −1.54; 95% CI: −2.24 to −0.84, p < 0.0001), 10-m walk test (10 MWT) (MD10−m steps: −2.44; 95% CI: −4.14 to −0.73, p = 0.005), and Berg Balance Scale (BBS) (MD: 2.59; 95% CI: 1.15–4.03, p = 0.0004) as compared to sham stimulation. Active rTMS was not significantly different from sham rTMS in changing the duration (MD10−m time: −1.29; 95% CI: −7.98 to 5.41, p = 0.71). No severe adverse events were observed in both sham stimulation and active rTMS groups.Conclusion: This meta-analysis provides limited evidence that rTMS may be beneficial in treating CA patients. However, these findings should be treated with caution due to the limitations of the smaller sample size and the inconsistent approach and target of rTMS treatment. Therefore, more large-scale RCTs are required to further validate our analytical findings.Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=295726, identifier: CRD42022295726.Keywords
This publication has 57 references indexed in Scilit:
- Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancerBMC Medical Research Methodology, 2014
- Cerebellar TMS in Treatment of a Patient with Cerebellar Ataxia: Evidence from Clinical, Biomechanics and Neurophysiological AssessmentsThe Cerebellum, 2013
- Developing core outcome sets for clinical trials: issues to considerTrials, 2012
- Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)Trials, 2012
- Physiology of repetitive transcranial magnetic stimulation of the human brainBrain Stimulation, 2010
- Reliability and validity of the scale for the assessment and rating of ataxia: A study in 64 ataxia patientsMovement Disorders, 2007
- Changes of cortical excitability of human motor cortex in spinocerebellar ataxia type 2: A study with paired transcranial magnetic stimulationJournal of the Neurological Sciences, 2002
- Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degenerationJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Therapeutic Efficacy of Transcranial Magnetic Stimulation for Hereditary Spinocerebellar Degeneration.The Tohoku Journal of Experimental Medicine, 1999
- Pathophysiology of cerebellar ataxiaMovement Disorders, 1992